Diabetes News

Endocrinology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ekinci EI et al. - The AER response to telmisartan ± HCT under habitual low salt intake can be blunted by NaCl supplementation. By contrast, when there is already a suppressed RAAS under habitual high dietary salt intake, the additional NaCl does not alter the AER response.

Related Articles

Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09    Relevance Score: 96%

Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/19/09    Relevance Score: 95%

Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study
Clinical Endocrinology, 10/16/09    Relevance Score: 94%

Periodontal Disease – The Overlooked Diabetes Complication
Nephrology Nursing Journal, 10/07/09    Relevance Score: 94%

Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes
Diabetic Medicine, 10/05/09    Relevance Score: 94%

Today in Diabetes...keeping you current

Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia
Hematology, 12/02/09

Perioperative management of diabetes: Translating evidence into practice
Cleveland Clinic Journal of Medicine, 12/02/09

Development and Validation of a Patient Self-assessment Score for Diabetes Risk
Annals of Internal Medicine, 12/02/09

Today in Hypertension...keeping you current

Prehypertension in Outpatient Obese Children
American Journal of Hypertension, 12/01/09

Aldosterone Contributes to Blood Pressure Variance and to Likelihood of Hypertension in Normal-Weight and Overweight African Americans
American Journal of Hypertension, 12/01/09

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09